The fund strategy is modeled on a plan devised by the European Investment Fund (EIF) last year to encourage corporations to support established venture capital firms, according to a source close to the fund.
Drug companies GlaxoSmithKline (GSK) and Johnson & Johnson (J&J) have committed in aggregate half of a €150m ($200m) healthcare venture fund to be managed by Index Ventures.
Index Life VI will have the other €75m committed by the venture capital manager’s existing limited partners.
The fund strategy is modeled on a plan devised by the European Investment Fund (EIF) last year to encourage corporations to support established venture capital firms, according to a source close to the fund.
Moncef…
